The Cleveland Clinic has agreed to stop providing gender-affirming medical care to transgender minors for the next 20 years as part of a settlement with the U.S. Department of Justice, a move that has sparked outrage from LGBTQ+ advocates and renewed concerns about the federal government’s escalating campaign against transgender healthcare.
Under the agreement, the Cleveland-based health system will no longer provide or facilitate puberty blockers, hormone therapy, or other gender-related medical treatments for patients under 18. The settlement also requires the hospital system to invest $2 million into services for people seeking detransition-related care and pay a financial penalty tied to allegations involving Medicaid billing practices. Cleveland Clinic denied intentionally submitting false claims and described the issue as an “unintentional coding issue” involving a small number of patients.
The deal follows a similar agreement reached between the DOJ and Texas Children’s Hospital last month, signaling a broader federal effort to pressure healthcare providers that offer gender-affirming care. The Department of Justice described both settlements as part of an ongoing national investigation into medical providers treating transgender youth.
While the practical impact on youth care in Ohio may be limited because the state already restricts gender-affirming treatment for minors, advocates warn the settlement establishes a troubling precedent. The agreement binds Cleveland Clinic for two decades, extending far beyond the current political landscape and potentially limiting future access even if Ohio law changes.
Transgender rights organizations and healthcare advocates were quick to condemn the arrangement. Critics argue the DOJ is using legal pressure and financial threats to discourage hospitals from providing evidence-based care supported by major medical organizations. The American Medical Association and the American Academy of Pediatrics continue to support gender-affirming care when medically appropriate and oppose blanket bans on treatment for transgender youth.
The settlement arrives amid a growing number of legal challenges to the Trump administration’s efforts targeting transgender healthcare. Federal courts have recently questioned the legality of DOJ investigations into providers, with judges allowing lawsuits against the administration’s enforcement actions to move forward.
Cleveland Clinic emphasized that the agreement does not affect gender-affirming care for adults, which will continue. However, for many transgender Ohio families, the announcement represents another shrinking avenue of support at a time when access to care is already under intense political and legal pressure.
As healthcare providers across the country watch closely, the Cleveland Clinic settlement may serve as a blueprint for future federal actions targeting institutions that provide transgender healthcare, raising concerns that the campaign against gender-affirming care is expanding beyond state legislatures and into the nation’s hospital systems.
